These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31151002)

  • 1. Biomechanics of cultured hepatic cells during different steatogenic hits.
    Baldini F; Bartolozzi A; Ardito M; Voci A; Portincasa P; Vassalli M; Vergani L
    J Mech Behav Biomed Mater; 2019 Sep; 97():296-305. PubMed ID: 31151002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD.
    Mashek DG
    Mol Metab; 2021 Aug; 50():101115. PubMed ID: 33186758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis.
    Gunn PJ; Pramfalk C; Millar V; Cornfield T; Hutchinson M; Johnson EM; Nagarajan SR; Troncoso-Rey P; Mithen RF; Pinnick KE; Traka MH; Green CJ; Hodson L
    Physiol Rep; 2020 Jul; 8(13):e14482. PubMed ID: 32643289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease.
    Breher-Esch S; Sahini N; Trincone A; Wallstab C; Borlak J
    BMC Med Genomics; 2018 Dec; 11(1):111. PubMed ID: 30547786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine.
    Grasselli E; Canesi L; Portincasa P; Voci A; Vergani L; Demori I
    Ann Hepatol; 2017; 16(5):707-719. PubMed ID: 28809727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.
    Takahara I; Akazawa Y; Tabuchi M; Matsuda K; Miyaaki H; Kido Y; Kanda Y; Taura N; Ohnita K; Takeshima F; Sakai Y; Eguchi S; Nakashima M; Nakao K
    PLoS One; 2017; 12(3):e0170591. PubMed ID: 28278289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unifying mathematical model of lipid droplet metabolism reveals key molecular players in the development of hepatic steatosis.
    Wallstab C; Eleftheriadou D; Schulz T; Damm G; Seehofer D; Borlak J; Holzhütter HG; Berndt N
    FEBS J; 2017 Oct; 284(19):3245-3261. PubMed ID: 28763157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipid droplet-associated proteins. Importance in steatosis, steatohepatitis and hepatocarcinogenesis].
    Straub BK
    Pathologe; 2015 Nov; 36 Suppl 2():146-52. PubMed ID: 26400566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid droplets disrupt mechanosensing in human hepatocytes.
    Chin L; Theise ND; Loneker AE; Janmey PA; Wells RG
    Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G11-G22. PubMed ID: 32463334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between Liver Stiffness and Steatosis in Obesity Conditions: In Vivo and In Vitro Studies.
    Baldini F; Khalil M; Bartolozzi A; Vassalli M; Di Ciaula A; Portincasa P; Vergani L
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Primary Human Hepatocytes and Hepatoma Cell Lines to Model the Effects of Fatty Acids, Fructose and Glucose on Liver Cell Lipid Accumulation.
    Huggett ZJ; Smith A; De Vivo N; Gomez D; Jethwa P; Brameld JM; Bennett A; Salter AM
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deranged hepatocyte intracellular Ca
    Ali ES; Rychkov GY; Barritt GJ
    Cell Calcium; 2019 Sep; 82():102057. PubMed ID: 31401389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raman spectroscopy analysis of lipid droplets content, distribution and saturation level in Non-Alcoholic Fatty Liver Disease in mice.
    Kochan K; Maslak E; Krafft C; Kostogrys R; Chlopicki S; Baranska M
    J Biophotonics; 2015 Jul; 8(7):597-609. PubMed ID: 25346221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis.
    Vergani L
    Curr Med Chem; 2019; 26(19):3439-3456. PubMed ID: 28521680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular imaging analysis of microvesicular and macrovesicular lipid droplets in non-alcoholic fatty liver disease by Raman microscopy.
    Minamikawa T; Ichimura-Shimizu M; Takanari H; Morimoto Y; Shiomi R; Tanioka H; Hase E; Yasui T; Tsuneyama K
    Sci Rep; 2020 Oct; 10(1):18548. PubMed ID: 33122711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new perspective on NAFLD: Focusing on lipid droplets.
    Scorletti E; Carr RM
    J Hepatol; 2022 Apr; 76(4):934-945. PubMed ID: 34793866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitofusin-2 induced by exercise modifies lipid droplet-mitochondria communication, promoting fatty acid oxidation in male mice with NAFLD.
    Bórquez JC; Díaz-Castro F; La Fuente FP; Espinoza K; Figueroa AM; Martínez-Ruíz I; Hernández V; López-Soldado I; Ventura R; Domingo JC; Bosch M; Fajardo A; Sebastián D; Espinosa A; Pol A; Zorzano A; Cortés V; Hernández-Alvarez MI; Troncoso R
    Metabolism; 2024 Mar; 152():155765. PubMed ID: 38142958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of hepassocin in the development of non-alcoholic fatty liver disease.
    Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
    J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD.
    Huang KT; Chen KD; Hsu LW; Kung CP; Li SR; Chen CC; Chiu KW; Goto S; Chen CL
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31968655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of HSD17B12 in mouse hepatocytes leads to reduced body weight and defect in the lipid droplet expansion associated with microvesicular steatosis.
    Heikelä H; Mairinoja L; Ruohonen ST; Rytkönen KT; de Brot S; Laiho A; Koskinen S; Suomi T; Elo LL; Strauss L; Poutanen M
    FASEB J; 2024 Sep; 38(17):e70034. PubMed ID: 39248019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.